[
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success",
    "summary": "On February 6, Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to 'Strong Buy'.",
    "url": "https://finnhub.io/api/news?id=c5b0fb1195f8ef4aa2d7ff1558b7ebc3037caf9ecfecab0c4219ac95c0126aab",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740152170,
      "headline": "Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success",
      "id": 132829801,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/462096667/image_462096667.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "On February 6, Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to 'Strong Buy'.",
      "url": "https://finnhub.io/api/news?id=c5b0fb1195f8ef4aa2d7ff1558b7ebc3037caf9ecfecab0c4219ac95c0126aab"
    }
  }
]